Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry).
Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T; J-BRAND Registry Group. Ueki K, et al. BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001787. doi: 10.1136/bmjdrc-2020-001787. BMJ Open Diabetes Res Care. 2021. PMID: 33441417 Free PMC article.
Glucagon underutilized among type 1 diabetes mellitus patients in Japan.
Murata T, Okazaki K, Yanagisawa K, Yamada K, Kuribayashi N, Totsuka Y, Hiyoshi T, Naka M, Sugimoto M, Aoki Y, Waki M, Furuya M, Kitaoka H, Oishi M, Shimizu I, Miyaoka H, Yamamoto T, Yamada K, Sakane N. Murata T, et al. Among authors: naka m. Diabetes Technol Ther. 2013 Sep;15(9):748-50. doi: 10.1089/dia.2012.0290. Epub 2013 Jun 12. Diabetes Technol Ther. 2013. PMID: 23758283
Fear of hypoglycemia and its determinants in insulin-treated patients with type 2 diabetes mellitus.
Sakane N, Kotani K, Tsuzaki K, Nishi M, Takahashi K, Murata T, Yamada K, Okazaki K, Yanagisawa K, Yamada K, Kuribayashi N, Totsuka Y, Hiyoshi T, Naka M, Sugimoto M, Aoki Y, Waki M, Furuya M, Kitaoka H, Oishi M, Shimizu I, Miyaoka H, Okada A, Yamamoto T. Sakane N, et al. Among authors: naka m. J Diabetes Investig. 2015 Sep;6(5):567-70. doi: 10.1111/jdi.12340. Epub 2015 Apr 2. J Diabetes Investig. 2015. PMID: 26417415 Free PMC article.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
242 results